Entrada Therapeutics, Inc. — Form D
Entrada Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-11-10. The offering totals $1.6M, of which $600K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-11-10
- Form: D
- Accession: 0001689375-16-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.6M
- Amount sold: $600K
- Remaining: $1000K
- Investors: 2
- Date of first sale: 2016-10-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-274261
Issuer
- Name: Entrada Therapeutics, Inc.
- CIK: 0001689375
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 6 TIDE STREET, BOSTON, MA, 02210
- Phone: 857-305-1825
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Kush Parmar | Executive Officer | San Francisco, CA |
| Louis Tartaglia | Executive Officer | BOSTON, MA |
| Louis Tartaglia | Director | BOSTON, MA |
| Todd Foley | Director | South San Francisco, CA |
| John F Crowley | Director | Princeton, NJ |
| Mario Saltarelli | Executive Officer | Newport Beach, CA |
| Christine Brennan | Director | Watertown, MA |
| Kush M Parmar | Director | Boston, MA |
| John Crowley | Director | Alameda, CA |
| Carole F Nuechterlein | Director | Boston, MA |
| Natarajan F Sethuraman | Executive Officer | Boston, MA |
| Todd F Foley | Director | Boston, MA |
| Peter F Kim | Director | Boston, MA |
| Nerissa F Kreher | Executive Officer | Boston, MA |
| Kory F Wentworth | Executive Officer | Boston, MA |
| Dipal Doshi | Director | Boston, MA |
| Dipal Doshi | Executive Officer | Boston, MA |
| Nathan F Dowden | Executive Officer | Boston, MA |
| Kush Parmar | Director | San Francisco, CA |
| Natarajan Sethuraman | Executive Officer | Boston, MA |
| Nathan Dowden | Executive Officer | Boston, MA |
| Anja Harmeier | Director | Boston, MA |
| Dehua Pei | Director | Boston, MA |
Other filings by this issuer (3)
More